MM-F12

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMM-F12
Drug Alias Namegenetically engineered hematopoietic stem cells (MolMed/Takara)genetically engineered hematopoietic stem cells (MolMed)MM-F12
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAsiaItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgc Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgc BiologicsTakara Bio Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A